On August 7, 2025, Cullinan Therapeutics, Inc. reported its financial results for the quarter ending June 30, 2025, and announced the resignations of directors Dr. Anne-Marie Martin and Dr. David P. Ryan, effective that same date. They also appointed Dr. Mittie Doyle and Dr. Andrew Allen as new board members, with each granted options valued at $359,000.